Agios Pharmaceuticals | Capitaux D'Emprunt



Loan Capital Changement Date
AbbVie USD 60.34B 1.83B 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 56.55B 305M 2024-12
Arrowhead Research USD 407.79M 14.61M 2024-12
Astellas Pharma JPY 585.51B 34.73B 2024-12
AstraZeneca USD 27.73B 2.29B 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Daiichi Sankyo JPY 101.03B 95M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Exelixis USD 0 0 2025-01
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Incyte USD 33.54M 5.32M 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
Merck USD 34.46B 520M 2024-12
Moderna USD 39M 586M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Agios Pharmaceuticals Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.